The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Abstract
BACKGROUND: The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF. METHODS AND RESULTS: We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction. CONCLUSIONS: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The last two alterations are likely triggered by microvascular endothelial inflammation [70].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [70]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,139
Souders, C. A., Bowers, S., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 1,018
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 735
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., & Kass, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.632745 · Cited by 699
Cited by
Sorted by citations
Items 101–200 of 638
Left Atrial Remodeling Mechanisms Associated with Atrial Fibrillation
Qiu, D., Peng, L., Ghista, D. N., & Wong, K. K. L. (2021) · Cardiovascular Engineering and Technology · doi:10.1007/s13239-021-00527-w · Cited by 89
Tschöpe, C., Müller, I., Xia, Y., Savvatis, K., Pappritz, K., Pinkert, S., Lassner, D., Heimesaat, M. M., Spillmann, F., Miteva, K., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003870 · Cited by 88
Self-citationTamaki, S., Mano, T., Sakata, Y., Ohtani, T., Takeda, Y., Kamimura, D., Omori, Y., Tsukamoto, Y., Ikeya, Y., Kawai, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068893 · Cited by 90
Savvatis, K., Müller, I., Fröhlich, M., Pappritz, K., Zietsch, C., Hamdani, N., Grote, K., Schieffer, B., Klingel, K., Linthout, S. V., et al. (2014) · Basic Research in Cardiology · doi:10.1007/s00395-014-0449-2 · Cited by 87
Self-citationSchwarzl, M., Hamdani, N., Seiler, S., Alogna, A., Manninger, M., Reilly, S. N., Zirngast, B., Kirsch, A. H., Paul Steendijk, A., Verderber, J., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00542.2015 · Cited by 89
Hua, Y., Sun, J.-Y., Lou, Y.-X., Sun, W., & Kong, X. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.03.016 · Cited by 90
Mongirdienė, A., Skrodenis, L., Varoneckaitė, L., Mierkytė, G., & Gerulis, J. (2022) · Biomedicines · doi:10.3390/biomedicines10030602 · Cited by 86
CD4+CD25+Foxp3+ regulatory T cells suppress cardiac fibrosis in the hypertensive heart
Kanellakis, P., Dinh, T. N., Agrotis, A., & Bobik, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328349c62d · Cited by 84
Müller, I., Vogl, T. J., Pappritz, K., Miteva, K., Savvatis, K., Rohde, D., Most, P., Laßner, D., Pieske, B. M., Kühl, U., et al. (2017) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004125 · Cited by 82
Self-citationMicrovascular endothelial dysfunction in heart failure with preserved ejection fraction
Lam, C. S. P., & Lund, L. H. (2016) · Heart · doi:10.1136/heartjnl-2015-308852 · Cited by 81
Role of cardiac inflammation in right ventricular failure
Sun, X., Abbate, A., & Bogaard, H. J. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx159 · Cited by 80
Heart failure with preserved ejection fraction: current management and future strategies
Tschöpe, C., Birner, C. M., Böhm, M., Bruder, O., Frantz, S., Luchner, A., Maier, L. S., Störk, S., Kherad, B., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1170-6 · Cited by 80
Self-citationEsposito, G., Cappetta, D., Russo, R., Rivellino, A., Ciuffreda, L. P., Roviezzo, F., Piegari, E., Berrino, L., Rossi, F., Angelis, A. D., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13686 · Cited by 81
Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
Mocan, M., Hognogi, L. D. M., Anton, F. P., Chiorescu, R. M., Goidescu, C. M., Stoia, M. A., & Fărcaș, A. D. (2019) · Disease Markers · doi:10.1155/2019/7583690 · Cited by 79
Dijk, C. V., Oosterhuis, N. R., Xu, Y. J., Brandt, M. M., Paulus, W. J., van Heerebeek, L., Duncker, D. J., Verhaar, M. C., Fontoura, D., Lourenço, A. P., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002760 · Cited by 78
Hypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarction
Choong, O. K., Chen, C.-Y., Zhang, J., Lin, J.-H., Lin, P.-J., Ruan, S., Kamp, T. J., & Hsieh, P. C. H. (2019) · Theranostics · doi:10.7150/thno.35218 · Cited by 79
Jin, X., Hung, C., Tay, W. T., Soon, D. K. N., Sim, D., Sung, K., Loh, S. Y., Lee, S., Jaufeerally, F. R., Ling, L. H., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2513 · Cited by 77
Extracellular matrix remodelling in obesity and metabolic disorders
Musale, V., Wasserman, D. H., & Kang, L. (2023) · Life Metabolism · doi:10.1093/lifemeta/load021 · Cited by 81
Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction
Shimizu, T., Narang, N., Chen, P., Yu, B., Knapp, M., Janardanan, J., Blair, J. E., & Liao, J. K. (2017) · JCI Insight · doi:10.1172/jci.insight.93187 · Cited by 80
Viral Myocarditis—From Pathophysiology to Treatment
Schultheiss, H.-P., Baumeier, C., Aleshcheva, G., Bock, C.-T., & Escher, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225240 · Cited by 75
Self-citationChild, N. M., Suna, G., Dabir, D., Yap, M.-L., Rogers, T., Kathirgamanathan, M., Arroyo, E., Hinojar, R., Mahmoud, I. Z., Young, C. P., et al. (2017) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jex309 · Cited by 75
Lipotoxicity: a driver of heart failure with preserved ejection fraction?
Leggat, J., Bidault, G., & Vidal‐Puig, A. (2021) · Clinical Science · doi:10.1042/cs20210127 · Cited by 74
Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction
Daou, D., Gillette, T. G., & Hill, J. A. (2023) · Physiology · doi:10.1152/physiol.00004.2023 · Cited by 80
Franssen, C., & Miqueo, A. G. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0812-z · Cited by 76
O’Connell, T. D., Block, R., Huang, S., & Shearer, G. C. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.12.003 · Cited by 76
Zotter‐Tufaro, C., Mascherbauer, J., Duca, F., Koell, B., Aschauer, S., Kammerlander, A. A., Panzenboeck, A., Sadushi‐Kolici, R., Bangert, C., Laimer, D., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.01.010 · Cited by 74
Pathophysiological insights into HFpEF from studies of human cardiac tissue
Fayyaz, A. U., Eltony, M., Prokop, L. J., Koepp, K. E., Borlaug, B. A., Dasari, S., Bois, M. C., Margulies, K. B., Maleszewski, J. J., Wang, Y., et al. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01067-1 · Cited by 75
Zhang, N., Ma, Q., You, Y., Xia, X., Xie, C., Huang, Y., Wang, Z., Ye, F., Yu, Z., & Xie, X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65802 · Cited by 71
Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure
Garcia, A. G., Wilson, R. M., Heo, J., Murthy, N. R., Baid, S., Ouchi, N., & Sam, F. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00298.2012 · Cited by 71
Integrating the Myocardial Matrix Into Heart Failure Recognition and Management
Spinale, F. G., & Zile, M. R. (2013) · Circulation Research · doi:10.1161/circresaha.113.300309 · Cited by 70
Hara, A., Kobayashi, H., Asai, N., Saito, S., Higuchi, T., Kato, K., Okumura, T., Bando, Y., Takefuji, M., Mizutani, Y., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.314806 · Cited by 69
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation
Chen, J., Norling, L. V., & Cooper, D. (2021) · Cells · doi:10.3390/cells10040881 · Cited by 69
Toba, H., Brás, L. E. D. C., Baicu, C. F., Zile, M. R., Lindsey, M. L., & Bradshaw, A. D. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00402.2014 · Cited by 69
Saiki, H., Moulay, G., Guenzel, A. J., Liu, W., Decklever, T. D., Classic, K. L., Pham, L., Chen, H. H., Burnett, J. C. J., Russell, S. J., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00124.2017 · Cited by 71
Multiple roles of cardiac macrophages in heart homeostasis and failure
Moskalik, A., Niderla‐Bielińska, J., & Ratajska, A. (2021) · Heart Failure Reviews · doi:10.1007/s10741-021-10156-z · Cited by 70
Abernethy, A. D., Raza, S. S., Sun, J., Anstrom, K. J., Tracy, R. P., Steiner, J., VanBuren, P., & LeWinter, M. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007385 · Cited by 69
The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies
Cai, Z., Wu, C., Xu, Y., Cai, J., Zhao, M., & Zu, L. (2022) · Aging and Disease · doi:10.14336/ad.2022.0523 · Cited by 69
Fujiu, K., & Nagai, R. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0357-x · Cited by 68
Du, Y., Han, J., Zhang, H., Xu, J., Jiang, L., & Ge, W. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000713 · Cited by 66
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
Friebel, J., Weithäuser, A., Witkowski, M., Rauch, B. H., Savvatis, K., Dörner, A., Tabaraie, T., Kašner, M., Moos, V., Bösel, D., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz117 · Cited by 68
Self-citationPrenner, S. B., Pillutla, R., Yenigalla, S., Gaddam, S., Lee, J. J., Obeid, M. J., Ans, A. H., Jehangir, Q., Kim, J., Zamani, P. L., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014716 · Cited by 64
From Risk Factors to Structural Heart Disease: The Role of Inflammation
Kalogeropoulos, A. P., Georgiopoulou, V. V., & Butler, J. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.08.002 · Cited by 63
Emerging role of liver X receptors in cardiac pathophysiology and heart failure
Cannon, M. V., van Gilst, W. H., & de Boer, R. A. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0520-7 · Cited by 63
Salvatore, T., Galiero, R., Caturano, A., Vetrano, E., Rinaldi, L., Coviello, F., Di Martino, A., Albanese, G., Colantuoni, S., Medicamento, G., et al. (2022) · Biomolecules · doi:10.3390/biom12020176 · Cited by 62
Inflammation in HFpEF: Key or circumstantial?
van Empel, V. P. M., & Rocca, H. B. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.04.110 · Cited by 62
Piaserico, S., Osto, E., Famoso, G., Zanetti, I., Gregori, D., Poretto, A., Iliceto, S., Peserico, A., & Tona, F. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.036 · Cited by 62
Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction
Mesquita, T., Zhang, R., de Couto, G., Valle, J., Sanchez, L., Rogers, R. G., Holm, K., Liu, W., Marbán, E., & Cingolani, E. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.02.007 · Cited by 63
Targeting obesity and diabetes to treat heart failure with preserved ejection fraction
Altara, R., Giordano, M., Nordén, E. S., Cataliotti, A., Kurdi, M., Bajestani, S. N., & Booz, G. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00160 · Cited by 61
Glezeva, N., Horgan, S. J., & Baugh, J. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.029 · Cited by 62
van Ham, W. B., Kessler, E. L., Oerlemans, M. I. F. J., Handoko, M. L., Sluijter, J. P. G., van Veen, T. A. B., den Ruijter, H. M., & de Jager, S. C. A. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.12.009 · Cited by 60
Cardiac Intercellular Communication: Are Myocytes and Fibroblasts Fair-Weather Friends?
Martin, M. L., & Blaxall, B. C. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9404-5 · Cited by 62
Cardiac acetylcholine inhibits ventricular remodeling and dysfunction under pathologic conditions
Roy, A., Dakroub, M., Tezini, G. C. S. V., Liu, Y., Guatimosim, S., Feng, Q., Salgado, H. C., Prado, V. F., Prado, M. A. M., & Gros, R. (2015) · The FASEB Journal · doi:10.1096/fj.15-277046 · Cited by 60
Gevaert, A. B., Lemmens, K., Vrints, C. J., & Craenenbroeck, E. M. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4865756 · Cited by 60
Follistatin like 1 regulates hypertrophy in heart failure with preserved ejection fraction
Tanaka, K., Valero-Muñoz, M., Wilson, R. M., Essick, E. E., Fowler, C. T., Nakamura, K., van den Hoff, M., Ouchi, N., & Sam, F. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.04.002 · Cited by 59
Cimino, G., Vaduganathan, M., Lombardi, C., Pagnesi, M., Vizzardi, E., Tomasoni, D., Adamo, M., Metra, M., & Inciardi, R. M. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14560 · Cited by 62
Heart Failure with Preserved Ejection Fraction: Current Understandings and Challenges
Andersen, M. J., & Borlaug, B. A. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0501-8 · Cited by 59
Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
Si, K., Wei, C., Xu, L., Zhou, Y., Lv, W., Dong, B., Wang, Z., Huang, Y., Wang, Y., & Chen, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770815 · Cited by 59
Immunometabolism at the Heart of Cardiovascular Disease
DeBerge, M., Chaudhary, R. K., Schroth, S. L., & Thorp, E. B. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.12.010 · Cited by 59
Macrophage-based therapeutic approaches for cardiovascular diseases
Sansonetti, M., Soodi, B. A., Thum, T., & Jung, M. (2024) · Basic Research in Cardiology · doi:10.1007/s00395-023-01027-9 · Cited by 57
Watson, C. J., Phelan, D. M. J., Xu, M., Collier, P. H., Neary, R., Smolenski, A., Ledwidge, M. T., McDonald, K., & Baugh, J. A. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-9 · Cited by 57
Hamdani, N., Costantino, S., Mügge, A., Lebeche, D., Tschöpe, C., Thum, T., & Paneni, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab197 · Cited by 56
Self-citationPüntmann, V. O., Arroyo, E., Baydés, R. H., Ngah, N. B., Kuo, Y., Dabir, D., Macmillan, A., Cummins, C., Higgins, D. M., Gaddum, N. R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03928 · Cited by 56
Patel, R. B., Colangelo, L. A., Bielinski, S. J., Larson, N. B., Ding, J., Allen, N. B., Michos, E. D., Shah, S. J., & Lloyd‐Jones, D. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.019390 · Cited by 56
Bonfioli, G. B., Rodella, L., Metra, M., & Vizzardi, E. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10450-6 · Cited by 58
Giamouzis, G., Schelbert, E. B., & Butler, J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003259 · Cited by 55
Reappraisal of Inflammatory Biomarkers in Heart Failure
Chaikijurajai, T., & Tang, W. H. W. (2020) · Current Heart Failure Reports · doi:10.1007/s11897-019-00450-1 · Cited by 54
Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction
Godo, S., TAKAHASHI, J. C., Yasuda, S., & Shimokawa, H. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.47 · Cited by 54
P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease
Zhou, J., Zhou, Z., Liu, X., Yin, H., Tang, Y., & Cao, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654425 · Cited by 55
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
Budde, H., Hassoun, R., Mügge, A., Kov́acs, Á., & Hamdani, N. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.928232 · Cited by 56
Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications
Naser, J. A., Lee, E., Scott, C. G., Kennedy, A. M., Pellikka, P. A., Lin, G., Pislaru, S. V., & Borlaug, B. A. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad592 · Cited by 53
Heart Failure with Preserved Ejection Fraction
Zouein, F. A., Brás, L. E. D. C., da Costa, D. V., Lindsey, M. L., Kurdi, M., & Booz, G. W. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31829a4e61 · Cited by 53
Kov́acs, Á., Alogna, A., Post, H., & Hamdani, N. (2016) · Netherlands Heart Journal · doi:10.1007/s12471-016-0814-x · Cited by 53
Myocardial Microvascular Dysfunction in Rheumatoid Arthritis
Amigues, I., Russo, C. A., Giles, J. T., Tuğcu, A., Weinberg, R. L., Bokhari, S., & Bathon, J. M. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.117.007495 · Cited by 53
Kapur, N. K. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960054 · Cited by 53
Plitt, G. D., Spring, J. T., Moulton, M. J., & Agrawal, D. K. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1497485 · Cited by 52
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
Luca, G. D. D., Cavalli, G., Campochiaro, C., Bruni, C., Tomelleri, A., Dagna, L., & Matucci‐Cerinic, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653950 · Cited by 52
Kazzi, M. E., Rayner, B. S., Chami, B., Dennis, J. M., Thomas, S. R., & Witting, P. K. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7928 · Cited by 53
The Role of Inflammation in the Pathophysiology of Heart Failure
Amara, M., Stoler, O., & Birati, E. Y. (2025) · Cells · doi:10.3390/cells14141117 · Cited by 53
Balint, B., Jaremek, V., Thorburn, V., Whitehead, S. N., & Sposato, L. A. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.06.004 · Cited by 51
Kresoja, K., Rommel, K., Wachter, R., Henger, S., Besler, C., Klöting, N., Schnelle, M., Hoffmann, A., Buttner, P. G., Ceglarek, U., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2291 · Cited by 51
Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling
Liu, X., Shi, G., & Guo, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.659666 · Cited by 54
Cardiac System during the Aging Process
Fernandes-Ribeiro, A. S., Zerolo, B. E., López‐Espuela, F., Sanchez, R., & Fernandes, V. S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0115 · Cited by 57
Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential
Fonseka, O., Gare, S. R., Chen, X., Zhang, J., Alatawi, N. H. O., Ross, C., & Liu, W. (2025) · Cells · doi:10.3390/cells14050324 · Cited by 52
The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction
Janssen-Telders, C., Eringa, E. C., de Groot, J. R., de Man, F. S., & Handoko, M. L. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf056 · Cited by 57
Prenner, S. B., Kumar, A., Zhao, L., Cvijic, M. E., Basso, M., Spires, T. E., Li, Z., Yarde, M., Bhattacharya, P., Zamani, P. L., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.11.006 · Cited by 50
Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis
Smolgovsky, S. A., Theall, B. P., Wagner, N., & Alcaide, P. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00545.2023 · Cited by 49
Diastolic myofilament dysfunction in the failing human heart
van der Velden, J. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-0960-3 · Cited by 49
Therapeutic Potential of HDL in Cardioprotection and Tissue Repair
Linthout, S. V., Frias, M. A., Singh, N., & Geest, B. D. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_17 · Cited by 48
Heart failure with preserved ejection fraction: Defining the function of ROS and NO
Zuo, L., Chuang, C., Hemmelgarn, B. T., & Best, T. M. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01149.2014 · Cited by 49
Linthout, S. V., Hamdani, N., Miteva, K., Koschel, A., Müller, I., Pinzur, L., Aberman, Z., Pappritz, K., Linke, W. A., & Tschöpe, C. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0130 · Cited by 47
Self-citationvan den Hoogen, P., de Jager, S. C. A., Huibers, M. M. H., Schoneveld, A. H., Puspitasari, Y. M., Valstar, G., Oerlemans, M. I. F. J., de Weger, R. A., Doevendans, P. A., den Ruijter, H. M., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14619 · Cited by 47
Pugliese, N. R., Fabiani, I., Conte, L., Nesti, L., Masi, S., Natali, A., Colombo, P. C., Pedrinelli, R., & Dini, F. L. (2020) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000974 · Cited by 47
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction
Tona, F., Montisci, R., Iop, L., & Civieri, G. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2021.01.277 · Cited by 48
Left Ventricular Diastolic Dysfunction in Ischemic Stroke: Functional and Vascular Outcomes
Park, H., Kim, B. J., Yoon, C., Yang, M., Han, M., & Bae, H. (2016) · Journal of Stroke · doi:10.5853/jos.2015.01697 · Cited by 46
Trippel, T. D., Linthout, S. V., Westermann, D., Lindhorst, R., Sandek, A., Ernst, S., Feuerstein, A., Kašner, M., Spillmann, F., González, A., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.960 · Cited by 46
Self-citationWilck, N., Markó, L., Balogh, A., Kräker, K., Herse, F., Bartolomaeus, H., Szijártó, I. A., Gollasch, M., Reichhart, N., Strauß, O., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96006 · Cited by 47
Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
Bai, B., Yang, W., Fu, Y., Foon, H. L., Tay, W. T., Yang, K., Luo, C., Gunaratne, J., Lee, P., Zile, M. R., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.07.008 · Cited by 50
PCSK9: A emerging participant in heart failure
Xu, Q., Zhao, Y.-M., He, N.-Q., Gao, R., Xu, W., Zhuo, X.-J., Ren, Z., Wu, C., & Liu, L. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114106 · Cited by 47
Contributions of Inflammation to Cardiometabolic Heart Failure with Preserved Ejection Fraction
Thorp, E. B., & Filipp, M. E. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-111523-023405 · Cited by 47
From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress
Franssen, C., Chen, H. S., Hamdani, N., & Paulus, W. J. (2015) · Heart · doi:10.1136/heartjnl-2015-307787 · Cited by 46
Metadata
- Authors
- Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., Poller, W., Schultheiss, H.-P., & Tschöpe, C.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Cardiology and Pneumology (D.W., D.L., M.K., C.Z., K.S., F.E., J.v.S., C.S., A.R., W.P., H.-P.S., C.T.), Charité, Universititäts-Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany, and Department of Cardiology (P.S.), Leiden University Medical Center, Leiden, The Netherlands.
- ORCID
- Venue
- Circulation Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2131184290
- Cited by
- 644
- References
- 55
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 53 · 2023: 50 · 2022: 57 · 2021: 58 · 2020: 49 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 35 · 2015: 42 · 2014: 30 · 2013: 21 · 2012: 17
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, cardiac inflammation, extracellular matrix remodeling, diastolic dysfunction, myocardial fibrosis, collagen deposition, MMP-1, TGF-beta, myofibroblasts, endomyocardial biopsy, left ventricular systolic function
- MeSH terms
- Adult, Aged, Biopsy, Cells, Cultured, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibrosis, Heart, Heart Failure, Humans, Inflammation, Male, Middle Aged, Myocardium, Stroke Volume, Case-Control Studies, Transforming Growth Factor beta, Ventricular Function, Left, Extracellular Matrix Proteins, Disease Progression, Matrix Metalloproteinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review